echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Crit Care: Plasma glutamine level at ICU admission is an independent risk factor for death in critically ill patients

    Crit Care: Plasma glutamine level at ICU admission is an independent risk factor for death in critically ill patients

    • Last Update: 2021-08-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    According to reports, the plasma glutamine concentration at the time of admission to the intensive care unit (ICU) exceeds the normal range and is associated with an increase in patient mortality


    Recently, a research article was published in Critical Care, an authoritative journal in the field of critical care medicine.


    The exclusion criteria for subjects in this study were under 18 years of age, re-admission, no informed consent, or "no resuscitation" medical advice on admission


    Survival curve

    269 ​​patients were included in the study, and 26 patients were hospitalized with hyperglutamineemia (≥930 µmol/L)


    It can be seen that hyperglutamineemia at ICU admission is an independent predictor of mortality, but it is not always associated with acute liver disease


    Hyperglutamineemia at ICU admission is an independent predictor of mortality, but it is not always associated with acute liver disease


    Original source:

    Marie Smedberg.


    Plasma glutamine status at intensive care unit admission : an independent risk factor for mortality in critical illness

    in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.